glp 1 menopause Interaction between GLP-1 Inhibitors and oral hormones Menopause Weight Gain & GLP-1

This product contains glutathione in its reduced form, which is the most active and potent form of the antioxidant

Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)

DISCLAIMER : The information on this website is for educational purposes only and is not intended as medical advice, diagnosis, or treatment

Vie Rayleigh is a very smart clean looking clinic with very professional staff